{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:39:12Z","timestamp":1790487552629,"version":"4.1.0"},"reference-count":48,"publisher":"American Association for Cancer Research (AACR)","issue":"11","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Interaction between the integrin VLA-4 on acute myelogenous leukemia (AML) cells with stromal fibronectin is a decisive factor in chemotherapeutic resistance. In this study, we provide a rationale for a drug repositioning strategy to blunt integrin activation in AML cells and restore their sensitivity to chemotherapy. Specifically, we demonstrate that the nontoxic tellurium compound AS101, currently being evaluated in clinical trials, can abrogate the acquired resistance of AML. Mechanistic investigations revealed that AS101 caused redox inactivation of adjacent thiols in the exofacial domain of VLA-4 after its ligation to stromal fibronectin. This effect triggered cytoskeletal conformational changes that decreased PI3K\/Akt\/Bcl2 signaling, an obligatory step in chemosensitization by AS101. In a mouse xenograft of AML derived from patient leukemic cells with high VLA-4 expression and activity, we demonstrated that AS101 abrogated drug resistance and prolonged survival in mice receiving chemotherapy. Decreased integrin activity was confirmed on AML cells in vivo. The chemosensitizing activity of AS101 persisted in hosts with defective adaptive and innate immunity, consistent with evidence that integrin deactivation was not mediated by heightening immune attack. Our findings provide a mechanistic rationale to reposition the experimental clinical agent, AS101, to degrade VLA-4\u2013mediated chemoresistance and improve clinical responses in patients with AML. Cancer Res; 74(11); 3092\u2013103. \u00a92014 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-13-2159","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T01:56:09Z","timestamp":1396576569000},"page":"3092-3103","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Redox Modulation of Adjacent Thiols in VLA-4 by AS101 Converts Myeloid Leukemia Cells from a Drug-Resistant to Drug-Sensitive State"],"prefix":"10.1158","volume":"74","author":[{"given":"Adi","family":"Layani-Bazar","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081C.A.I.R. Institute, The Safdi\u00e8 AIDS and Immunology Research Center, The Mina & Everard Goodman Faculty of Life Sciences; 2Chemistry Department, Bar-Ilan University, Ramat-Gan; 3Department of Hematology, Kaplan Medical Center, Rehovot, Israel; and 4Laboratory of Molecular Biology and Immunology, Biomedical Research Center, National Institute on Aging, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itai","family":"Skornick","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081C.A.I.R. Institute, The Safdi\u00e8 AIDS and Immunology Research Center, The Mina & Everard Goodman Faculty of Life Sciences; 2Chemistry Department, Bar-Ilan University, Ramat-Gan; 3Department of Hematology, Kaplan Medical Center, Rehovot, Israel; and 4Laboratory of Molecular Biology and Immunology, Biomedical Research Center, National Institute on Aging, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Berrebi","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081C.A.I.R. Institute, The Safdi\u00e8 AIDS and Immunology Research Center, The Mina & Everard Goodman Faculty of Life Sciences; 2Chemistry Department, Bar-Ilan University, Ramat-Gan; 3Department of Hematology, Kaplan Medical Center, Rehovot, Israel; and 4Laboratory of Molecular Biology and Immunology, Biomedical Research Center, National Institute on Aging, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maor H.","family":"Pauker","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081C.A.I.R. Institute, The Safdi\u00e8 AIDS and Immunology Research Center, The Mina & Everard Goodman Faculty of Life Sciences; 2Chemistry Department, Bar-Ilan University, Ramat-Gan; 3Department of Hematology, Kaplan Medical Center, Rehovot, Israel; and 4Laboratory of Molecular Biology and Immunology, Biomedical Research Center, National Institute on Aging, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad","family":"Noy","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081C.A.I.R. Institute, The Safdi\u00e8 AIDS and Immunology Research Center, The Mina & Everard Goodman Faculty of Life Sciences; 2Chemistry Department, Bar-Ilan University, Ramat-Gan; 3Department of Hematology, Kaplan Medical Center, Rehovot, Israel; and 4Laboratory of Molecular Biology and Immunology, Biomedical Research Center, National Institute on Aging, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alon","family":"Silberman","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081C.A.I.R. Institute, The Safdi\u00e8 AIDS and Immunology Research Center, The Mina & Everard Goodman Faculty of Life Sciences; 2Chemistry Department, Bar-Ilan University, Ramat-Gan; 3Department of Hematology, Kaplan Medical Center, Rehovot, Israel; and 4Laboratory of Molecular Biology and Immunology, Biomedical Research Center, National Institute on Aging, Baltimore, Maryland"},{"name":"Authors' Affiliations:\u20081C.A.I.R. Institute, The Safdi\u00e8 AIDS and Immunology Research Center, The Mina & Everard Goodman Faculty of Life Sciences; 2Chemistry Department, Bar-Ilan University, Ramat-Gan; 3Department of Hematology, Kaplan Medical Center, Rehovot, Israel; and 4Laboratory of Molecular Biology and Immunology, Biomedical Research Center, National Institute on Aging, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Albeck","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081C.A.I.R. Institute, The Safdi\u00e8 AIDS and Immunology Research Center, The Mina & Everard Goodman Faculty of Life Sciences; 2Chemistry Department, Bar-Ilan University, Ramat-Gan; 3Department of Hematology, Kaplan Medical Center, Rehovot, Israel; and 4Laboratory of Molecular Biology and Immunology, Biomedical Research Center, National Institute on Aging, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan L.","family":"Longo","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081C.A.I.R. Institute, The Safdi\u00e8 AIDS and Immunology Research Center, The Mina & Everard Goodman Faculty of Life Sciences; 2Chemistry Department, Bar-Ilan University, Ramat-Gan; 3Department of Hematology, Kaplan Medical Center, Rehovot, Israel; and 4Laboratory of Molecular Biology and Immunology, Biomedical Research Center, National Institute on Aging, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yona","family":"Kalechman","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081C.A.I.R. Institute, The Safdi\u00e8 AIDS and Immunology Research Center, The Mina & Everard Goodman Faculty of Life Sciences; 2Chemistry Department, Bar-Ilan University, Ramat-Gan; 3Department of Hematology, Kaplan Medical Center, Rehovot, Israel; and 4Laboratory of Molecular Biology and Immunology, Biomedical Research Center, National Institute on Aging, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Sredni","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081C.A.I.R. Institute, The Safdi\u00e8 AIDS and Immunology Research Center, The Mina & Everard Goodman Faculty of Life Sciences; 2Chemistry Department, Bar-Ilan University, Ramat-Gan; 3Department of Hematology, Kaplan Medical Center, Rehovot, Israel; and 4Laboratory of Molecular Biology and Immunology, Biomedical Research Center, National Institute on Aging, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2014,5,29]]},"reference":[{"key":"2022061705005497400_bib1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0301-472X(01)00612-9","article-title":"Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5)","volume":"29","author":"Garrido","year":"2001","journal-title":"Exp Hematol"},{"key":"2022061705005497400_bib2","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1182\/blood.V82.10.3125.3125","article-title":"Human acute myeloid leukemia cells bind to bone marrow stroma via a combination of beta-1 and beta-2 integrin mechanisms","volume":"82","author":"Bendall","year":"1993","journal-title":"Blood"},{"key":"2022061705005497400_bib3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nm909","article-title":"Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia","volume":"9","author":"Matsunaga","year":"2003","journal-title":"Nat Med"},{"key":"2022061705005497400_bib4","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1182\/blood.V89.7.2311","article-title":"Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the Medical Research Council","volume":"89","author":"Hann","year":"1997","journal-title":"Blood"},{"key":"2022061705005497400_bib5","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1056\/NEJM199909303411407","article-title":"Acute myeloid leukemia","volume":"341","author":"Lowenberg","year":"1999","journal-title":"N Engl J Med"},{"key":"2022061705005497400_bib6","doi-asserted-by":"crossref","first-page":"18307","DOI":"10.1016\/S0021-9258(17)32306-2","article-title":"\u201cInside-out\u201d signal transduction inhibited by isolated integrin cytoplasmic domains","volume":"269","author":"Chen","year":"1994","journal-title":"J Biol Chem"},{"key":"2022061705005497400_bib7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0092-8674(00)81892-9","article-title":"Suppression of integrin activation: a novel function of a Ras\/Raf-initiated MAP kinase pathway","volume":"88","author":"Hughes","year":"1997","journal-title":"Cell"},{"key":"2022061705005497400_bib8","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1182\/blood-2002-06-1646","article-title":"Enzymatically catalyzed disulfide exchange is required for platelet adhesion to collagen via integrin alpha2beta1","volume":"102","author":"Lahav","year":"2003","journal-title":"Blood"},{"key":"2022061705005497400_bib9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0076-6879(02)53045-7","article-title":"Redox control of integrin adhesion receptors","volume":"353","author":"Smith","year":"2002","journal-title":"Methods Enzymol"},{"key":"2022061705005497400_bib10","doi-asserted-by":"crossref","first-page":"39964","DOI":"10.1074\/jbc.M007041200","article-title":"A redox site involved in integrin activation","volume":"275","author":"Yan","year":"2000","journal-title":"J Biol Chem"},{"key":"2022061705005497400_bib11","doi-asserted-by":"crossref","first-page":"32435","DOI":"10.1074\/jbc.M404387200","article-title":"Conformational regulation of alpha 4 beta 1-integrin affinity by reducing agents. \u201cInside-out\u201d signaling is independent of and additive to reduction-regulated integrin activation","volume":"279","author":"Chigaev","year":"2004","journal-title":"J Biol Chem"},{"key":"2022061705005497400_bib12","doi-asserted-by":"crossref","first-page":"8861","DOI":"10.1021\/bi002902i","article-title":"Mechanism of integrin activation by disulfide bond reduction","volume":"40","author":"Yan","year":"2001","journal-title":"Biochemistry"},{"key":"2022061705005497400_bib13","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1200\/JCO.1995.13.9.2342","article-title":"Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposide","volume":"13","author":"Sredni","year":"1995","journal-title":"J Clin Oncol"},{"key":"2022061705005497400_bib14","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/jnci\/88.18.1276","article-title":"Predominance of TH1 response in tumor-bearing mice and cancer patients treated with AS101","volume":"88","author":"Sredni","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"2022061705005497400_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/330173a0","article-title":"A new immunomodulating compound (AS-101) with potential therapeutic application","volume":"330","author":"Sredni","year":"1987","journal-title":"Nature"},{"key":"2022061705005497400_bib16","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1096\/fj.03-0552fje","article-title":"Hair growth induction by the Tellurium immunomodulator AS101: association with delayed terminal differentiation of follicular keratinocytes and ras-dependent up-regulation of KGF expression","volume":"18","author":"Sredni","year":"2004","journal-title":"FASEB J"},{"key":"2022061705005497400_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/(SICI)1097-0215(19960103)65:1<97::AID-IJC17>3.0.CO;2-F","article-title":"The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models","volume":"65","author":"Sredni","year":"1996","journal-title":"Int J Cancer"},{"key":"2022061705005497400_bib18","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1158\/0008-5472.CAN-03-3179","article-title":"Ammonium trichloro(dioxoethylene-o,o')tellurate (AS101) sensitizes tumors to chemotherapy by inhibiting the tumor interleukin 10 autocrine loop","volume":"64","author":"Sredni","year":"2004","journal-title":"Cancer Res"},{"key":"2022061705005497400_bib19","doi-asserted-by":"crossref","first-page":"36984","DOI":"10.1074\/jbc.M003279200","article-title":"The platelet integrin alpha IIbbeta 3 has an endogenous thiol isomerase activity","volume":"275","author":"O'Neill","year":"2000","journal-title":"J Biol Chem"},{"key":"2022061705005497400_bib20","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1096\/fj.06-7500com","article-title":"Multifunctional tellurium molecule protects and restores dopaminergic neurons in Parkinson's disease models","volume":"21","author":"Sredni","year":"2007","journal-title":"FASEB J"},{"key":"2022061705005497400_bib21","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/j.1471-4159.2007.04615.x","article-title":"The organotellurium compound ammonium trichloro(dioxoethylene-0,0\u2032) tellurate enhances neuronal survival and improves functional outcome in an ischemic stroke model in mice","volume":"102","author":"Okun","year":"2007","journal-title":"J Neurochem"},{"key":"2022061705005497400_bib22","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1111\/j.1742-4658.2007.05842.x","article-title":"The organotellurium compound ammonium trichloro(dioxoethylene-o,o')tellurate reacts with homocysteine to form homocystine and decreases homocysteine levels in hyperhomocysteinemic mice","volume":"274","author":"Okun","year":"2007","journal-title":"FEBS J"},{"key":"2022061705005497400_bib23","doi-asserted-by":"crossref","first-page":"6525","DOI":"10.1016\/S0021-9258(18)68673-9","article-title":"Human plasma lecithin-cholesterol acyltransferase. The vicinal nature of cysteine 31 and cysteine 184 in the catalytic site","volume":"263","author":"Jauhiainen","year":"1988","journal-title":"J Biol Chem"},{"key":"2022061705005497400_bib24","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1074\/jbc.275.6.4369","article-title":"Vicinal dithiol-binding agent, phenylarsine oxide, inhibits inducible nitric-oxide synthase gene expression at a step of nuclear factor-kappaB DNA binding in hepatocytes","volume":"275","author":"Oda","year":"2000","journal-title":"J Biol Chem"},{"key":"2022061705005497400_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1182\/blood.V98.2.405","article-title":"Mitochondrial membrane sensitivity to depolarization in acute myeloblastic leukemia is associated with spontaneous in vitro apoptosis, wild-type TP53, and vicinal thiol\/disulfide status","volume":"98","author":"Pallis","year":"2001","journal-title":"Blood"},{"key":"2022061705005497400_bib26","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1110\/ps.9.12.2436","article-title":"Presence of closely spaced protein thiols on the surface of mammalian cells","volume":"9","author":"Donoghue","year":"2000","journal-title":"Protein Sci"},{"key":"2022061705005497400_bib27","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1038\/sj.leu.2400847","article-title":"Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia","volume":"11","author":"Lacombe","year":"1997","journal-title":"Leukemia"},{"key":"2022061705005497400_bib28","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1128\/MCB.01358-10","article-title":"Functional cooperation between the proteins Nck and ADAP is fundamental for actin reorganization","volume":"31","author":"Pauker","year":"2011","journal-title":"Mol Cell Biol"},{"key":"2022061705005497400_bib29","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1126\/science.1068539","article-title":"Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells","volume":"296","author":"Zacharias","year":"2002","journal-title":"Science"},{"key":"2022061705005497400_bib30","doi-asserted-by":"crossref","first-page":"28071","DOI":"10.1074\/jbc.274.40.28071","article-title":"The Talin head domain binds to integrin beta subunit cytoplasmic tails and regulates integrin activation","volume":"274","author":"Calderwood","year":"1999","journal-title":"J Biol Chem"},{"key":"2022061705005497400_bib31","first-page":"6571","article-title":"Breaking the integrin hinge. A defined structural constraint regulates integrin signaling","volume":"271","author":"Hughs","year":"1996","journal-title":"J Biol Chem"},{"key":"2022061705005497400_bib32","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1083\/jcb.131.3.807","article-title":"Beta 3-endonexin, a novel polypeptide that interacts specifically with the cytoplasmic tail of the integrin beta 3 subunit","volume":"131","author":"Shattil","year":"1995","journal-title":"J Cell Biol"},{"key":"2022061705005497400_bib33","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1073\/pnas.041618598","article-title":"Locking in alternate conformations of the integrin alphaLbeta2 I domain with disulfide bonds reveals functional relationships among integrin domains","volume":"98","author":"Lu","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061705005497400_bib34","doi-asserted-by":"crossref","first-page":"38628","DOI":"10.1074\/jbc.M105737200","article-title":"Probing conformational changes in the I-like domain and the cysteine-rich repeat of human beta 3 integrins following disulfide bond disruption by cysteine mutations: identification of cysteine 598 involved in alphaIIbbeta3 activation","volume":"276","author":"Chen","year":"2001","journal-title":"J Biol Chem"},{"key":"2022061705005497400_bib35","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1182\/blood.V98.8.2432","article-title":"A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype","volume":"98","author":"Ruiz","year":"2001","journal-title":"Blood"},{"key":"2022061705005497400_bib36","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1182\/blood-2002-02-0418","article-title":"Disruption of the long-range GPIIIa Cys(5)-Cys(435) disulfide bond results in the production of constitutively active GPIIb-IIIa (alpha(IIb)beta(3)) integrin complexes","volume":"100","author":"Sun","year":"2002","journal-title":"Blood"},{"key":"2022061705005497400_bib37","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nsb779","article-title":"Cysteine-rich module structure reveals a fulcrum for integrin rearrangement upon activation","volume":"9","author":"Beglova","year":"2002","journal-title":"Nat Struct Biol"},{"key":"2022061705005497400_bib38","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1182\/blood-2003-01-0334","article-title":"New insights into the structural basis of integrin activation","volume":"102","author":"Xiong","year":"2003","journal-title":"Blood"},{"key":"2022061705005497400_bib39","doi-asserted-by":"crossref","first-page":"14737","DOI":"10.1073\/pnas.2434516100","article-title":"Redox regulation of surface protein thiols: identification of integrin alpha-4 as a molecular target by using redox proteomics","volume":"100","author":"Laragione","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061705005497400_bib40","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/eji.200737556","article-title":"Ligand binding of leukocyte integrin very late antigen-4 involves exposure of sulfhydryl groups and is subject to redox modulation","volume":"38","author":"Liu","year":"2008","journal-title":"Eur J Immunol"},{"key":"2022061705005497400_bib41","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1039\/c0ob00086h","article-title":"Tellurium: an element with great biological potency and potential","volume":"8","author":"Ba","year":"2010","journal-title":"Org Biomol Chem"},{"key":"2022061705005497400_bib42","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1021\/bi0620712","article-title":"S-Nitrosylation of platelet alphaIIbbeta3 as revealed by Raman spectroscopy","volume":"46","author":"Walsh","year":"2007","journal-title":"Biochemistry"},{"key":"2022061705005497400_bib43","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.leukres.2008.10.014","article-title":"Prognostic value of CXCR4 and FAK expression in acute myelogenous leukemia","volume":"33","author":"Tavernier-Tardy","year":"2009","journal-title":"Leuk Res"},{"key":"2022061705005497400_bib44","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1182\/blood-2004-02-0566","article-title":"Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia","volume":"104","author":"Rombouts","year":"2004","journal-title":"Blood"},{"key":"2022061705005497400_bib45","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1182\/blood-2006-05-024844","article-title":"CXCR4 is a prognostic marker in acute myelogenous leukemia","volume":"109","author":"Spoo","year":"2007","journal-title":"Blood"},{"key":"2022061705005497400_bib46","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/cncr.22510","article-title":"Overexpression of CXCR4 predicts adverse overall and event-free survival in patients with unmutated FLT3 acute myeloid leukemia with normal karyotype","volume":"109","author":"Konoplev","year":"2007","journal-title":"Cancer"},{"key":"2022061705005497400_bib47","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1182\/blood-2007-12-124818","article-title":"Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia","volume":"113","author":"Becker","year":"2009","journal-title":"Blood"},{"key":"2022061705005497400_bib48","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1158\/0008-5472.CAN-03-3005","article-title":"Expression of focal adhesion kinase in acute myeloid leukemia is associated with enhanced blast migration, increased cellularity, and poor prognosis","volume":"64","author":"Recher","year":"2004","journal-title":"Cancer Res"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/74\/11\/3092\/2702808\/3092.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/74\/11\/3092\/2702808\/3092.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T11:41:42Z","timestamp":1655466102000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/74\/11\/3092\/592742\/Redox-Modulation-of-Adjacent-Thiols-in-VLA-4-by"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,29]]},"references-count":48,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,5,29]]},"published-print":{"date-parts":[[2014,6,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-13-2159","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22400336","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22400324","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22400318.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22400333","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22400318","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22400324.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22400339.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22400321.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22400339","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22400327","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6505562.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6505562","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22400330.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22400333.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22400336.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22400327.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22400321","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22400330","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,29]]}}}